NASDAQ
No price data available for this timeframe.
Neumora Therapeutics, Inc. Common Stock (NMRA) has a current ratio of 5.87x as of Tuesday, May 26, 2026. This represents a 63.18% decrease compared to its 12-month average of 15.95x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.